These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1102475

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
    Nishio S, Kishimoto T, Maekawa M, Kawakita J, Hayahara N, Yuki K, Morikawa Y, Yasumoto R, Kato Y, Funai K.
    Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of advanced prostatic carcinoma with estramustine phosphate (Estracyt).
    Jönsson G, Högberg B, Nilsson T.
    Scand J Urol Nephrol; 1977 Nov; 11(3):231-8. PubMed ID: 339329
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oral estramustine phosphate (Estracyt): a broad phase II study.
    Halpern J, Catane R.
    J Med; 1984 Nov; 15(1):35-43. PubMed ID: 6593404
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA, Chantada Abal V, Lamas Meilan AC, González Martín M.
    Actas Urol Esp; 1984 Nov; 8(5):399-402. PubMed ID: 6524487
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relationship of prior hormonal therapy to subsequent estramustine phosphate treatment in advanced prostatic cancer.
    Slack NH, Wajsman Z, Mittelman A, Bruno S, Murphy GP.
    Urology; 1979 Dec; 14(6):549-54. PubMed ID: 390810
    [Abstract] [Full Text] [Related]

  • 13. Estramustine phosphate: a specific chemotherapeutic agent?
    Von Hoff DD, Rozencweig M, Slavik M, Muggia FM.
    J Urol; 1977 Apr; 117(4):464-6. PubMed ID: 850319
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of advanced estrogen-resistant cancer of the prostate with estramustine phosphate. A phase-2 study].
    Trykker HU.
    Ugeskr Laeger; 1985 Oct 14; 147(42):3310-2. PubMed ID: 4082315
    [No Abstract] [Full Text] [Related]

  • 15. Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt).
    Vahlensieck W, Wegner G.
    Scand J Urol Nephrol Suppl; 1980 Oct 14; 55():147-9. PubMed ID: 6938018
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Estramustine phosphate therapy in carcinoma of the prostate.
    Andersson L, Edsmyr F, Jönsson G, Könyves I.
    Recent Results Cancer Res; 1977 Oct 14; (60):73-7. PubMed ID: 866798
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Estramustine phosphate in the treatment of advanced prostatic cancer.
    Küss R, Khoury S, Richard F, Fourcade F, Frantz P, Capelle JP.
    Br J Urol; 1980 Feb 14; 52(1):29-33. PubMed ID: 7426949
    [Abstract] [Full Text] [Related]

  • 20. Combined therapy of advanced prostatic carcinoma with estramustine and prednimustine.
    Catane R, Kaufman J, Mittelman A, Murphy GP.
    J Urol; 1977 Mar 14; 117(3):332-5. PubMed ID: 839597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.